D48.1: Neoplasma dengan Perilaku Tidak Pasti atau Tidak Diketahui pada Jaringan Ikat dan Jaringan Lunak Lainnya

World Health Organization. (2020). WHO Classification of Tumours of Soft Tissue and Bone. 5th Edition. Lyon: IARC Press.

Goldblum, J.R., Folpe, A.L., & Weiss, S.W. (2020). Enzinger and Weiss's Soft Tissue Tumors. 7th Edition. Philadelphia: Elsevier.

Kasper, B., et al. (2022). 'European consensus approach for desmoid tumors: a joint European consensus initiative.' Annals of Oncology, 33(5), 456-467.

Nishida, Y., et al. (2021). 'Management of desmoid-type fibromatosis: a survey of Japanese experts.' International Journal of Clinical Oncology, 26(2), 345-354.

Skubitz, K.M. (2017). 'Biology and treatment of aggressive fibromatosis or desmoid tumor.' Mayo Clinic Proceedings, 92(6), 947-964.

WHO. (2019). International Classification of Diseases for Mortality and Morbidity Statistics. 10th Revision. Geneva: World Health Organization.

Fiore, M., et al. (2019). 'Desmoid-type fibromatosis: a chronic disease?' Annals of Oncology, 30(8), 1232-1233.

Penel, N., et al. (2021). 'Management of desmoid tumours: a nationwide survey of labelled reference networks in France.' European Journal of Cancer, 148, 1-10.

Gounder, M.M., et al. (2018). 'Sorafenib for Advanced and Refractory Desmoid Tumors.' New England Journal of Medicine, 379(25), 2417-2428.

Cates, J.M.M., & Stricker, T.P. (2019). 'Soft Tissue Tumors of Uncertain Differentiation.' Surgical Pathology Clinics, 12(1), 165-199.